Pharmacogenomics: Optimizing Drug Therapy through Genetic Testing
-
Register
- Non-member - $50
- Member - $40
- *Further discounts may apply once you log in.
Already registered?
Log in now.
This presentation reviews emerging therapies for multiple sclerosis (MS), focusing on novel treatment approaches beyond disease-modifying agents. We discuss the potential of remyelination strategies, neuroprotective therapies, and immune-modulating agents in slowing disease progression and improving clinical outcomes for MS patients.
Key:
Complete
Next
Failed
Available
Locked